| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |